UBS O'Connor’s AdaptHealth AHCO Stock Holding History

UBS O'Connor’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-707,425	Closed	-$7.22M	–	319
2019 Q3	$7.22M	Buy	+707,425	New	+$7.22M	0.2%	95

Other funds holding AHCO

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

AIM

Assured Investment Management New York $79.5M AUM 115.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

CRC

Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

MAM

Myriad Asset Management North Point, Hong Kong $722M AUM 11.94% 1-Year Est. Return

ECM

ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

UBS O'Connor's AHCO Position: Q4 2019 in Review

UBS O'Connor sold out of AdaptHealth (AHCO) in Q4 2019, closing a stake of 707,425 shares — an estimated $7.22M sold.

UBS O'Connor first reported a position in AHCO in Q3 2019 and held it in 1 quarter. The position peaked at $7.22M in Q3 2019. 23 funds tracked by Wall St. Rank hold AHCO as of Q4 2019.

UBS O'Connor reported no remaining AdaptHealth position as of Q4 2019 after selling out during the quarter.
UBS O'Connor sold 707,425 AdaptHealth shares in Q4 2019, an estimated $7.22M.
UBS O'Connor first reported a position in AdaptHealth in Q3 2019 and held it in 1 quarter.
UBS O'Connor's AdaptHealth position peaked at $7.22M in Q3 2019.
23 funds tracked by Wall St. Rank held AdaptHealth as of Q4 2019.

Based on UBS O'Connor's 13F filing for Q4 2019, filed 14 Feb 2020.